Enable Injections, the developer of wearable medical devices that enable at-home self-administration of high volume injectable drugs and biologics, has opened its new Cincinnati, OH manufacturing facility.

“Our newly certified facility with its clean room, warehousing capacity and exceptional process flow, rivals any pharmaceutical company manufacturing facility,” said Tom Docherty, operations manager, Enable Injections.

Small-scale manufacturing of the company’s On Body Delivery Systems (OBDS) has begun at the Ohio facility with clinical trials commencing in the near future.

The scalable 41,000 square foot Cincinnati facility, with a second clean room planned, will manufacture device quantities of up to one million units. In February, Enable Injections and Flex entered into a product development and manufacturing partnership for large scale builds of over a million device units.

“Our many pharmaceutical company partners and site visitors who are considering cross labeled or co-packaged product have been impressed,” said Eileen Rogers, vice president of operations, Enable Injections.

“We look forward to continuing to work with partners to develop patient-friendly drug delivery technology that shows great potential to add value to the healthcare system by boosting compliance while lowering costs,” said Michael Hooven, chief executive officer, Enable Injections.